Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Current Leases (2022 - 2026)

HeartSciences filings provide 5 years of Current Leases readings, the most recent being $133927.0 for Q1 2026.

  • On a quarterly basis, Current Leases rose 16.44% to $133927.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $133927.0, a 16.44% increase, with the full-year FY2025 number at $119518.0, up 16.84% from a year prior.
  • Current Leases hit $133927.0 in Q1 2026 for HeartSciences, up from $128977.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $133927.0 in Q1 2026 to a low of $29535.0 in Q2 2023.
  • Median Current Leases over the past 5 years was $102293.0 (2024), compared with a mean of $94525.6.
  • Biggest five-year swings in Current Leases: plummeted 67.53% in 2023 and later skyrocketed 246.35% in 2024.
  • HeartSciences' Current Leases stood at $31232.0 in 2022, then soared by 202.46% to $94463.0 in 2023, then increased by 17.13% to $110645.0 in 2024, then grew by 16.57% to $128977.0 in 2025, then grew by 3.84% to $133927.0 in 2026.
  • The last three reported values for Current Leases were $133927.0 (Q1 2026), $128977.0 (Q4 2025), and $124173.0 (Q3 2025) per Business Quant data.